Compounds > n-(7-(4-nitrobenzo-2-oxa-1,3-diazole))-6-aminocaproyl sphingosine
Page last updated: 2024-09-03

n-(7-(4-nitrobenzo-2-oxa-1,3-diazole))-6-aminocaproyl sphingosine and ha14-1

n-(7-(4-nitrobenzo-2-oxa-1,3-diazole))-6-aminocaproyl sphingosine has been researched along with ha14-1 in 1 studies

Compound Research Comparison

Studies
(n-(7-(4-nitrobenzo-2-oxa-1,3-diazole))-6-aminocaproyl sphingosine)		Trials
(n-(7-(4-nitrobenzo-2-oxa-1,3-diazole))-6-aminocaproyl sphingosine)		Recent Studies (post-2010)
(n-(7-(4-nitrobenzo-2-oxa-1,3-diazole))-6-aminocaproyl sphingosine)		Studies
(ha14-1)		Trials
(ha14-1)		Recent Studies (post-2010) (ha14-1)
78012104031

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hirabayashi, Y; Ichikawa, S; Nagano-Ito, M; Nakamura, Y; Niino, S1

Other Studies

1 other study(ies) available for n-(7-(4-nitrobenzo-2-oxa-1,3-diazole))-6-aminocaproyl sphingosine and ha14-1

ArticleYear
A small molecule inhibitor of Bcl-2, HA14-1, also inhibits ceramide glucosyltransferase.
    Biochemical and biophysical research communications, 2013, Apr-05, Volume: 433, Issue:2

    Topics: 4-Chloro-7-nitrobenzofurazan; Animals; Apoptosis; Benzopyrans; Cell Line; Ceramides; Drug Evaluation, Preclinical; Enzyme Inhibitors; Glucosyltransferases; Humans; Inhibitory Concentration 50; Kinetics; Melanoma, Experimental; Mice; Nitriles; Proto-Oncogene Proteins c-bcl-2

2013